scPharmaceuticals Inc. (SCPH) Tops Q4 EPS by 7c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q4 EPS of ($0.35), $0.07 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $5.47 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• KB Home (KBH) PT Raised to $56 at Truist Securities
• Paychex beats fourth quarter EPS estimates, stock slides